Urothelial carcinoma in situ with “early papillary formation” vs “lateral spread/shoulder lesion” of prior high-grade noninvasive papillary urothelial carcinoma: A survey of pathologist and urologist interpretations
American Journal of Clinical Pathology · 19.04.2025 · 163 (4) · 629-640
DOI: 10.1093/ajcp/aqae167 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical Pathology, online erschienen am 25.12.2024. Verfasst von Ankur R Sangoi und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Stanford University Medical Center, Stanford, CA, United States. Hauptthemen laut MEDLINE: Carcinoma in Situ, Urinary Bladder Neoplasms, Carcinoma, Papillary, Carcinoma, Transitional Cell. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Objectives
Urothelial carcinoma in situ (CIS) with early papillary formation is terminology sometimes used to suggest incipient high-grade papillary urothelial carcinoma (PUC) but may lead to confusion between true CIS and lateral flat spread of PUC.
Methods
It remains unclear how pathologists and urologists interpret this scenario, so a survey was circulated to 68 pathologists (group 1 = 28 academic genitourinary pathologists; group 2 = 17 pathologists with a self-reported genitourinary focus; group 3 = 23 pathologists self-reported as not genitourinary specialists) and 32 urologists.
Results
Regarding atypical urothelial lesions that appear mainly flat but contain possible papillae, group 3 was more likely to label this as CIS compared with groups 1 and 2 (35% for group 3 vs 13% for groups 1 and 2), while groups 1 and 2 more often adopted another descriptive diagnosis, such as “CIS with early papillary features” (38% for groups 1 and 2 vs 13% for group 3). Among all 3 groups, group 1 was most likely to diagnose concomitant CIS and PUC in the same specimen but in different tissue fragments (58%). Pagetoid spread was reported to favor CIS predominantly by group 1 (61%). Urologists felt that the term lateral spread/shoulder was unclear (75%) and preferred early PUC (44%) or PUC with early growth (44%). Half (53%) of urologists felt that reporting CIS instead of lateral spread of PUC would change management.
Conclusions
Documentation of flat lesions lacks consensus among pathologists and may benefit from standardized terminology. Moreover, the distinction between CIS and early or lateral spread of PUC is not always clear to urologists and can influence disease management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Stanford University Medical Center, Stanford, CA, United States.
- Chesapeake Urology, Beltsville, MD, United States.
- Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
- Department of Pathology and Laboratory Medicine, Cleveland Clinic Foundation, Cleveland, OH, United States.
- Department of Pathology, University of Chicago School of Medicine, Chicago, IL, United States.
- Department of Pathology, Virginia Commonwealth University School of Medicine, Richmond, VA, United States.
ORCID-Profile: Steven C Smith, Sean R Williamson
Zitieren
APA
Sangoi, A. R., Shahabi, A., Hirsch, M. S., Kao, C. S., Deebajah, M., Barletta, J. A., Paner, G. P., Smith, S. C., Grignon, D. J., Compérat, E., Amin, M. B., Maclean, F., Shah, R. B., Iczkowski, K. A., Delprado, W., Cheng, L., Pan, C. C., McKenney, J. K., Ro, J. Y., …, & Williamson, S. R. (2025). Urothelial carcinoma in situ with “early papillary formation” vs “lateral spread/shoulder lesion” of prior high-grade noninvasive papillary urothelial carcinoma: A survey of pathologist and urologist interpretations. American Journal of Clinical Pathology, 163(4), 629-640. https://doi.org/10.1093/ajcp/aqae167
Vancouver
Sangoi AR, Shahabi A, Hirsch MS, Kao CS, Deebajah M, Barletta JA, et al. Urothelial carcinoma in situ with “early papillary formation” vs “lateral spread/shoulder lesion” of prior high-grade noninvasive papillary urothelial carcinoma: A survey of pathologist and urologist interpretations. American Journal of Clinical Pathology. 2025;163(4):629-640. doi:10.1093/ajcp/aqae167
BibTeX
@article{Sangoi2025,
author = {Sangoi, Ankur R and Shahabi, Ali and Hirsch, Michelle S and Kao, Chia-Sui Sunny and Deebajah, Mustafa and Barletta, Justine A and Paner, Gladell P and Smith, Steven C and Grignon, David J and Compérat, Eva and Amin, Mahul B and Maclean, Fiona and Shah, Rajal B and Iczkowski, Kenneth A and Delprado, Warick and Cheng, Liang and Pan, Chin-Chen and McKenney, Jesse K and Ro, Jae Y and Khani, Francesca and Montironi, Rodolfo and Robinson, Brian D and Al-Ahmadie, Hikmat and Epstein, Jonathan I and Trpkov, Kiril and Tretiakova, Maria and Shen, Steven S and Alanee, Shaheen and Weight, Christopher J and Akgul, Mahmut and Williamson, Sean R},
title = {Urothelial carcinoma in situ with “early papillary formation” vs “lateral spread/shoulder lesion” of prior high-grade noninvasive papillary urothelial carcinoma: A survey of pathologist and urologist interpretations},
journal = {American Journal of Clinical Pathology},
year = {2025},
volume = {163},
number = {4},
pages = {629--640},
doi = {10.1093/ajcp/aqae167}
}
EUVIMED